NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Stability of Morphine, Codeine, and 6-Acetylmorphine in Blood at Different Sampling and Storage Conditions

Author(s): Papoutsis I, Nikoloau P, Pistos C, Dona A, Stefanidou M, Spiliopoulou C, Athanaselis S

Publication: J Forensic Sci, 2014, Vol. 59(2), Page 550-4

Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of tube material, anticoagulant type, storage temperature and duration, and freeze-thaw cycling on levels of spiked morphine, codeine and 6-acetyl morphine in blood specimens.

Conclusion of Paper

After 1 month of storage of whole blood at 4 degrees C, morphine levels declined by 12-23%, codeine levels declined by 12-22%, and 6-acetyl-morphine levels declined by 13-95%. After 3 months of storage of whole blood at -20 degrees C, morphine levels declined by 18-32%, codeine levels declined by 7-19%, and acetyl morphine levels declined by 8-74%. After three freeze-thaw cycles, levels of morphine, codeine and 6-acetyl-morphine declined by 3.97%, 10.3%, and 20.8%, respectively, in whole blood. Generally, the addition of NaF and storage of blood specimens at -20 degrees C instead of 4 degrees C increased the stability of morphine, codeine and 6-acetyl-morphine. Further, storage of blood in glass tubes, as opposed to polypropylene or polystyrene, generally increased the stability of morphine and codeine, and the use of oxalate instead of EDTA as an anticoagulant increased the stability of 6-acetyl-morphine in blood specimens.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of tube material, anticoagulant type, storage temperature and duration, and freeze-thaw cycling on levels of spiked morphine, codeine and 6-acetyl morphine in blood specimens. Pooled blood specimens were spiked with morphine and codeine or 6-acetyl-morphine. During freeze-thaw experiments, blood was thawed for 4 h at room temperature and then refrozen at -20 degrees C for 24 h. Specimens stored at 4 degrees C were assayed after 1 day, 1 week, 2 weeks and 1 month, but specimens stored at -20 degrees C were assayed after 1 week, 2 weeks, 1 month, 2 months and 3 months.

    Summary of Findings:

    After 1 month of storage of whole blood at 4 degrees C, morphine levels declined by 12-23%, codeine levels declined by 12-22%, and acetyl morphine levels declined by 13-95%. After 3 months of storage of whole blood at -20 degrees C, morphine levels declined by 18-32%, codeine levels declined by 7-19%, and acetyl morphine levels declined by 8-74%. Compared to initial levels, after 1 day at 4 degrees C, morphine and codeine concentrations were 5% higher in specimens stored in glass tubes and 5% lower in blood stored in polypropylene or polystyrene, regardless of anticoagulant. In contrast, after 1 day at 4 degrees C, acetyl-morphine levels were 1-20% lower than baseline, with higher levels observed in specimens anticoagulated with sodium oxalate than K2EDTA. After 1 week at -20 degrees C, levels of morphine and codeine were 2% higher to 6% lower, and levels of 6-acetyl-morphine 2-10% lower than initial levels, depending on tube material and anticoagulant type, but significance was not stated. After three freeze-thaw cycles, levels of morphine, codeine and 6-acetyl-morphine declined by 3.97%, 10.3%, and 20.8%, respectively, in whole blood specimens. Generally, the addition of NaF and storage at -20 degrees C instead of 4 degrees C increased the stability of morphine, codeine and 6-acetyl-morphine in spiked pooled whole blood. Further, storage of spiked blood in glass tubes, as opposed to polypropylene or polystyrene, generally increased the stability of morphine and codeine, and the use of oxalate instead of K2EDTA as an anticoagulant generally increased the stability of 6-acetyl-morphine.

    Biospecimens
    Preservative Types
    • None (Fresh)
    • Other Preservative
    • Frozen
    Diagnoses:
    • Not specified
    Platform:
    AnalyteTechnology Platform
    Small molecule GC-MS
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage temperature 4 degrees C
    -20 degrees C
    Storage Storage duration 1 day
    1 week
    2 weeks
    1 month
    2 months
    3months
    Storage Freeze/thaw cycling 0 cycles
    3 cycles
    Storage Type of storage container Glass tube
    Polypropylene tube
    Polystyrene tube
    Biospecimen Preservation Type of fixation/preservation None (fresh)
    Frozen
    Refrigeration
    Biospecimen Acquisition Anticoagulant Sodium fluoride
    Sodium oxalate
    Potassium EDTA

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...